GERN Investors:  March 23, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

generic securities image

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation on behalf of investors who purchased the common stock of Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) between March 19, 2018 and September 26, 2018, inclusive (the “Class Period”). [Read more…]

Geron Investor A­­lert:  March 23, 20­­­20 Filing Deadline in Class Action – Contact Lieff Cabraser

generic securities image

Lieff Cabraser  announces that class action litigation has been filed on behalf of investors who purchased shares of the common stock of Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN) between March 19, 2018 and September 26, 2018, inclusive (the “Class Period”). [Read more…]

Mohawk Shareholder Alert:  March 3, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

securities

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased shares of the common stock of Mohawk Industries, Inc. (“Mohawk” or the “Company”) (NYSE: MHK) between April 28, 2017 and July 25, 2019, inclusive (the “Class Period”). [Read more…]

Daniel Chiplock Co-Authors Piece in Support of the SEC’s Continued Use of Disgorgement for the Harvard Law School Forum on Corporate Governance

Daniel Chiplock Co-Writes Essay in Support of SEC Disgorgement Power

Lieff Cabraser partner Daniel P. Chiplock, along with Tyler Gellasch of the Healthy Markets Association and Andy Green of the Center for American Progress, wrote a piece published by the Harvard Law School Forum on Corporate Governance in support of the Securities & Exchange Commission’s continued ability to compel disgorgement as a remedy in financial fraud cases. The Supreme Court is set to hear oral argument in March on whether the SEC may continue seeking disgorgement,  compelling giving-up of all ill-gotten gains—in civil enforcement proceedings. [Read more…]

Lieff Cabraser Files Amicus Brief in U.S. Supreme Court Supporting the SEC’s Ability to Seek Disgorgement of Gains from Securities Law Violations in Federal Court

U.S. Supreme Court

Lieff Cabraser today filed an amicus brief in the U.S. Supreme Court arguing for the importance of the ability of the Securities and Exchange Commission to continue to seek disgorgement of the gains from securities law violations in federal court in order to effectively deter securities fraud and promote the public policies that form the foundation of U.S. securities laws. [Read more…]

Exelon Investor Alert:  February 14, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

generic securities

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the securities.of Exelon Corporation (“Exelon” or the “Company”) (Nasdaq: EXC) between February 9, 2019 and November 1, 2019, inclusive (the “Class Period”). [Read more…]

HEXO Investor Alert: January 27, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

generic securities image

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action litigation on behalf of investors who purchased or otherwise acquired the common stock of  HEXO Corp. (“HEXO” or the “Company”) (NYSE: HEXO) between January 25, 2019 and November 15, 2019, inclusive (the “Class Period”). [Read more…]

Plantronics Shareholders: January 13, 2020 Filing Deadline in Securities Class Action

securities

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Plantronics, Inc. (“Plantronics” or the “Company”) (NYSE: PLT) between January 2, 2018 and November 5, 2019, inclusive (the “Class Period”). [Read more…]

Baxter Shareholder Alert: January 24, 2020 Filing Deadline in Class Action– Contact Lieff Cabraser

generic securities image

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the securities of  Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) between February 21, 2019 and October 23, 2019, inclusive (the “Class Period”). [Read more…]

Exelon Shareholder Alert: February 14, 2020 Filing Deadline in Class Action – Contact Lieff Cabraser

Securities Class Litigation

SAN FRANCISCO, CA – (December 26, 2019) – The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Exelon Corporation (“Exelon” or the “Company”) (Nasdaq: EXC) between February 9, 2019 and November 1, 2019, inclusive (the “Class Period”). [Read more…]

HEXO Corp. Shareholder Class Action:  January 27, 2020 Filing Deadline – Contact Lieff Cabraser

generic securities image

Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of HEXO Corp. (“HEXO” or the “Company”) (NYSE: HEXO) between January 25, 2019 and November 15, 2019, inclusive (the “Class Period”). [Read more…]

Baxter International Inc. Shareholder Class Action: January 24, 2020 Filing Deadline – Contact Lieff Cabraser

generic securities image
Lieff Cabraser announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) between February 21, 2019 and October 23, 2019, inclusive (the “Class Period”).

[Read more…]

Chemours Shareholder Class Action: Reminder about December 9, 2019 Filing Deadline – Contact Lieff Cabraser

Lieff Cabraser reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the common stock of The Chemours Company (“Chemours” or the “Company”) (NYSE:CC) between February 16, 2017 and August 1, 2019, inclusive (the “Class Period”). [Read more…]

Myriad Genetics Investors: Filing Deadline in MYGN Class Action Approaches – Contact Lieff Cabraser

MYGN Investors: Important Reminder about November 26, 2019 Filing Deadline in Class Action - Contact Lieff Cabraser

Lieff Cabraser reminds investors that securities fraud class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN) between September 2, 2016 and August 13, 2019, inclusive (the “Class Period”). [Read more…]

MYGN Investors: Important Reminder about November 26, 2019 Filing Deadline in Class Action – Contact Lieff Cabraser

MYGN Investors: Important Reminder about November 26, 2019 Filing Deadline in Class Action - Contact Lieff Cabraser

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in the class action that has been filed on behalf of investors who purchased or otherwise acquired the securities of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ:MYGN) between September 2, 2016 and August 13, 2019, inclusive (the “Class Period”). [Read more…]

The Chemours Company Investors: December 9, 2019 Filing Deadline in CC Class Action – Contact Lieff Cabraser

The Chemours Company Investors: December 9, 2019 Filing Deadline in CC Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA – (October 25, 2019) – The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces announces that securities fraud class action litigation has been filed on behalf of investors who purchased or otherwise acquired the common stock of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) between February 16, 2017 and August 1, 2019, inclusive (the “Class Period”). [Read more…]

Plaintiffs Provide Notice to Wells Fargo Shareholders of $320 Million Settlement of Wells Fargo Shareholder Derivative Litigation

Securities Fraud

San Francisco—(BUSINESSWIRE)–IN RE WELLS FARGO & COMPANY SHAREHOLDER DERIVATIVE LITIGATION, Lead Case No. 3:16-cv-05541-JST (N.D. Cal.)

TO: ALL RECORD AND BENEFICIAL OWNERS OF WELLS FARGO & COMPANY COMMON STOCK AS OF FEBRUARY 26, 2019 (THE “RECORD DATE”), WHO CONTINUE TO OWN SUCH SHARES (“WELLS FARGO SHAREHOLDERS”)

YOU ARE HEREBY NOTIFIED, that pursuant to an Order of the United States District Court for the Northern District of California, a hearing will be held on August 1, 2019, at 2 p.m., before the Honorable Jon S. Tigar, United States District Judge, at the United States District Court for the Northern District of California, 450 Golden Gate Avenue, San Francisco, California 94102, for the purpose of determining whether the proposed settlement of the above captioned derivative action (the “Derivative Action”), with a total settlement value of $320 million (as described below), should be approved as fair, reasonable and adequate, and whether a judgment dismissing the Defendants (as identified in the Stipulation of Settlement (“Stipulation”)) from the Derivative Action with prejudice should be entered. [Read more…]

$320M Wells Fargo Derivative Suit Settlement Granted First Round of Approval

Securities Fraud

A California federal judge has granted preliminary approval to a proposed $320 million settlement that would end shareholders’ derivative litigation relating to Wells Fargo’s fake accounts scandal. Plaintiffs in the suit, including the Fire & Police Pension Association of Colorado and the City of Birmingham Retirement and Relief System allege that since at least 2011, the Board and executive management of Wells Fargo knew or consciously disregarded that its employees were illicitly creating millions of deposit and credit card accounts for their customers, without those customers’ consent, in order to meet aggressive sales goals. [Read more…]

Lieff Cabraser to Proceed with Lawsuit in Denmark for Money Laundering Fraud Against Danske Bank

Securities and financial fraud

Lieff Cabraser, working with an international coalition of law firms including Danish law firm Németh Sigetty, will proceed with a lawsuit against Danske Bank A/S (“Danske” or the “Bank”) to pursue compensation for damaged investors after revelations of alleged money laundering, financial mismanagement, and deficient regulatory disclosures. [Read more…]

The Intercept: Will Shareholders Lose the Right to Sue Over Corporate Fraud?

Securities and financial fraud

In partnership with the Investigative Fund, The Intercept has published a powerful piece calling attention to proposed changes to the securities laws that may keep shareholders from being able to sue corporations that violate the law to shareholders’ detriment. The right to a trial may be replaced with mandatory arbitration agreements that will shunt shareholder lawsuits into private, closed-door arbitration funded by the very corporations alleged to have committed the fraud. [Read more…]